Frequently Asked Question
What Is an Observed Collection?
An observed collection is a specific drug test procedure where a trained observer directly watches the donor's urine sample. This step helps prevent tampering or substitution of the urine specimen. The observer protects the sample's integrity by following these steps:
- Instructing the donor to raise clothing above the waist, lower clothing and underpants, and turn around to show there is no prosthetic or other device (49 CFR 40.67).
- Watching the urine go from the donor's body into the collection container without losing sight of the container.
- Confirming the donor does not turn away or conceal the collection process.
- Observed collections are typically required when there is a suspicion of specimen tampering, following a prior invalid test result, or as part of a return-to-duty or follow-up testing program. The observer must be the same sex as the donor (49 CFR 40.67), and the procedures must respect the donor's privacy while maintaining the collection's integrity.
Proper training in drug and alcohol testing helps collectors understand when and how to conduct observed collections correctly, maintaining the integrity of the testing process and complying with regulatory requirements. This knowledge helps avoid errors and helps confirm that procedures are followed, protecting both the donor's rights and the accuracy of the test results.
How did the 2026 DOT rule change observed collections?
A DOT rule published May 11, 2026, and effective June 10, 2026, changed how observed collections work while oral fluid testing is not yet available (91 FR 25507). The 2023 rule called for an oral fluid test when an observer could not be easily provided and in certain other situations. Because there are no HHS-certified oral fluid laboratories, that requirement could not be met, so the 2026 rule directs a directly observed urine collection in those cases instead (91 FR 25507).
Under the amended 49 CFR 40.67, when oral fluid testing is not yet available and no same-sex observer is present at the collection site, the collector contacts the Designated Employer Representative (DER). The DER either arranges for a same-sex observer to be present at the time of the collection or sends the employee to a collection site acceptable to the employer for a directly observed urine collection. The rule also replaced the word "gender" with "sex" in 49 CFR 40.67, 40.69, and 40.145 (91 FR 25507).
Once oral fluid testing is available and a same-sex observer cannot be found, the collector follows any employer standing order that allows oral fluid testing in that situation. Without a standing order, the collector contacts the DER, who directs an oral fluid test at the site if the site can conduct one or sends the employee to an acceptable site for the oral fluid test. Availability means at least two HHS-certified oral fluid laboratories, a qualified oral fluid collector, and a conforming collection device. After HHS gives notice of the second certified laboratory, an 18-month grace period begins, and an employer that is ready to use oral fluid testing during that period must do so (49 CFR 40.67).
As of the November 2, 2026 HHS list, no laboratories were certified to test oral fluid specimens (91 FR 68964).
We are not a law firm. The information on this website is for informational purposes only and may not be up to date. Always consult a licensed attorney for personalized legal advice.